195 related articles for article (PubMed ID: 17317569)
1. High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones.
Tropak MB; Blanchard JE; Withers SG; Brown ED; Mahuran D
Chem Biol; 2007 Feb; 14(2):153-64. PubMed ID: 17317569
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients.
Tropak MB; Reid SP; Guiral M; Withers SG; Mahuran D
J Biol Chem; 2004 Apr; 279(14):13478-87. PubMed ID: 14724290
[TBL] [Abstract][Full Text] [Related]
3. beta-hexosaminidase in cultured normal and mutant human fibroblasts: an immunohistochemical and biochemical investigation.
Elsafi ME; Elbashir MI; Hultberg B; Isaksson A; Hägerstrand I; Stenram U
Scand J Clin Lab Invest; 1991 Dec; 51(8):711-4. PubMed ID: 1839650
[TBL] [Abstract][Full Text] [Related]
4. Lending a helping hand, screening chemical libraries for compounds that enhance beta-hexosaminidase A activity in GM2 gangliosidosis cells.
Tropak MB; Mahuran D
FEBS J; 2007 Oct; 274(19):4951-61. PubMed ID: 17894780
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of enantiomeric beta-N-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease.
Rountree JS; Butters TD; Wormald MR; Boomkamp SD; Dwek RA; Asano N; Ikeda K; Evinson EL; Nash RJ; Fleet GW
ChemMedChem; 2009 Mar; 4(3):378-92. PubMed ID: 19145603
[TBL] [Abstract][Full Text] [Related]
6. [Beta-N-acetyl-hexosaminidase--the enzyme of Tay-Sachs and Sandhoff diseases].
Zwierz K; Juszkiewicz J; Arciuch L; Gindzieński A
Postepy Biochem; 1992; 38(3):127-32. PubMed ID: 1461844
[No Abstract] [Full Text] [Related]
7. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
[TBL] [Abstract][Full Text] [Related]
8. In situ assessment of beta-hexosaminidase activity.
Lacorazza HD; Jendoubi M
Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
[TBL] [Abstract][Full Text] [Related]
9. sp
González-Cuesta M; Herrera-González I; García-Moreno MI; Ashmus RA; Vocadlo DJ; García Fernández JM; Nanba E; Higaki K; Ortiz Mellet C
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1364-1374. PubMed ID: 35575117
[TBL] [Abstract][Full Text] [Related]
10. Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis.
Maegawa GH; Tropak M; Buttner J; Stockley T; Kok F; Clarke JT; Mahuran DJ
J Biol Chem; 2007 Mar; 282(12):9150-61. PubMed ID: 17237499
[TBL] [Abstract][Full Text] [Related]
11. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
[TBL] [Abstract][Full Text] [Related]
12. Tay-Sachs and Sandhoff diseases: enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards.
Chamoles NA; Blanco M; Gaggioli D; Casentini C
Clin Chim Acta; 2002 Apr; 318(1-2):133-7. PubMed ID: 11880123
[TBL] [Abstract][Full Text] [Related]
13. The lysosomal hexosaminidase isozymes.
Mahuran D; Novak A; Lowden JA
Isozymes Curr Top Biol Med Res; 1985; 12():229-88. PubMed ID: 3886595
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
[TBL] [Abstract][Full Text] [Related]
15. When an inhibitor promotes activity.
Bouvier M
Chem Biol; 2007 Mar; 14(3):241-2. PubMed ID: 17379138
[No Abstract] [Full Text] [Related]
16. Enzyme immunoassay of beta-hexosaminidase A and B in serum: carrier detection of GM2-gangliosidoses, and equivalence of enzyme activity and enzyme protein reactivity.
Isaksson A; Hultberg B; Masson P; Landels E; Fensom A
Clin Chem; 1993 Jul; 39(7):1412-5. PubMed ID: 8330398
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.
Trasler J; Saberi F; Somani IH; Adamali HI; Huang JQ; Fortunato SR; Ritter G; Gu M; Aebersold R; Gravel RA; Hermo L
Endocrinology; 1998 Jul; 139(7):3280-8. PubMed ID: 9645704
[TBL] [Abstract][Full Text] [Related]
18. Isoenzymes of N-acetyl-beta-hexosaminidase.
Zwierz K; Zalewska A; Zoch-Zwierz A
Acta Biochim Pol; 1999; 46(3):739-51. PubMed ID: 10698282
[TBL] [Abstract][Full Text] [Related]
19. Highly phosphomannosylated enzyme replacement therapy for GM2 gangliosidosis.
Tsuji D; Akeboshi H; Matsuoka K; Yasuoka H; Miyasaki E; Kasahara Y; Kawashima I; Chiba Y; Jigami Y; Taki T; Sakuraba H; Itoh K
Ann Neurol; 2011 Apr; 69(4):691-701. PubMed ID: 21520232
[TBL] [Abstract][Full Text] [Related]
20. Unusual thermolability properties of beta-hexosaminidase: studies of enzyme from cultured cells and clinical implications.
Prence EM; Zalewski I; Natowicz MR
Am J Med Genet; 1996 Nov; 65(4):320-4. PubMed ID: 8923943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
